Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Coronary Stents Industry is Anticipated to Reach US$ 13.88 Billion in 2025 By Materials (Nitinol, Polymer, Nickel, Gold, Tantalum, Stainless Steel)




(PharmaNewsWire.Com, June 10, 2018 ) The Coronary Stents market is anticipated to grow at a CAGR of 7.8% and reach US$ 13.88 Bn by 2025

Coronary stents are narrow expandable tubes, which are used to treat coronary diseases such as, artery blockage. These stents are used to perform angioplasty to keep the arteries open in the treatment of coronary artery disease. Coronary stents are usually made up of metal mesh, which acts against corrosion and helps to prevent the artery from recoiling or blocking again.

In our study, we have segmented the coronary stents market by type, absorption rate, material and end-users. The coronary stents by type is segmented as biodegradable stents, bare metal stents and drug eluting stents. The absorption rate segment was further segmented as the slow absorption rate and fast absorption rate. The coronary stents market, by material can be categorized as nitinol, polymers, nickel, gold, tantalum, stainless steel and cobalt alloy metal stents. The end user segment can be segmented into ambulatory surgical centers, hospitals and cardiac centers. Geographically, the market for coronary stents was categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).

Free | Request a Sample copy of Report: http://bit.ly/2JdCgac

The coronary stents market is estimated to grow at a CAGR of 7.8% during the forecast period from 2018 to 2025. The market for coronary stents is estimated to reach US$ 13,879.0 Mn by 2025. The market for coronary stents has been witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The coronary stents market is subject to strict and mandated regulatory policies. The companies operating in the market follow stringent regulations of the manufacturing guidelines. In addition, these manufacturing companies are focusing to invest in R&D to develop advanced products for end users such as, hospitals, ambulatory surgical centers, and the cardiac centers, among others.

The market for coronary stents is well established in North America region, especially in the U.S and Canada. Rising prevalence of various types of cardiac diseases and subsequent usage of coronary stents to treat these diseases is one of the major factors for the growth of coronary stents market in the country. According to the American Heart Association (AHA), in 2016, nearly 15.5 million persons aged above 20 years in the US have coronary heart diseases (CHD). The rising number of the coronary heart diseases need more number of coronary stents, hence, the coronary stents market is likely to grow during the forecast period.

Inquire Befor Buying on this Report: http://bit.ly/2JgN0oA

The major players operating in the market of coronary stents market include Microport Scientific Corporation, Medtronic PLC, Biosensors International Group, Ltd., Abbott Laboratories, Vascular Concepts Limited, Biotronik SE & Co. Kg, Stentys SA, B. Braun Melsungen AG, Translumina GmbH, and Terumo Corporation.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: http://www.theinsightpartners.com/

The Insight Partners

Sameer Joshi

+91 9666111581

sam@theinsightpartners.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC